THE FULL SOLUTION

Serial Number 97642582
606

Registration Progress

Application Filed
Oct 21, 2022
Under Examination
Nov 7, 2023
Approved for Publication
Sep 12, 2023
Published for Opposition
Sep 12, 2023
Registered

Trademark Image

THE FULL SOLUTION

Basic Information

Serial Number
97642582
Filing Date
October 21, 2022
Published for Opposition
September 12, 2023
Abandonment Date
June 10, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 10, 2024
Classes
042

Rights Holder

Oxford Biomedica Solutions LLC

16
Address
One Patriots Park
Bedford, MA 01730

Ownership History

Oxford Biomedica Solutions LLC

Original Applicant
16
Bedford, MA

Oxford Biomedica Solutions LLC

Owner at Publication
16
Bedford, MA

Legal Representation

Attorney
Michelle Rosenberg

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Jul 12, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 10, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 7, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 12, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 12, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 23, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 7, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 4, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 6, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 25, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Testing, research, or development of pharmaceutical and biotechnological preparations for cell and gene therapy; product research, development and testing of pharmaceutical and biotechnological preparations for cell and gene therapy for others; Platform as a Service (PaaS) services featuring computer software platforms for developing products and processes in the fields of cell and gene therapy, for manufacturing cell and gene therapy products, and for commercializing cell and gene therapy products and processes

Classification

International Classes
042